BeStock  

AngioDynamics ANGO

US equityMarket cap rank #3663Medical Instruments & Supplies
$11.73 −$0.08 (-0.68%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $11.73 0.00%
Open$11.62
Prev close$11.81
Day range$11.52 – $11.81
Volume363.7K
Market cap$493.30M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-0.5%BearishTrading below the 20-day average of $11.79
Price vs 50-day average-14.9%BearishTrading below the 50-day average of $13.79
Price vs 200-day average-6.2%BearishTrading below the 200-day average of $12.51
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)39.5BearishMomentum leans negative
MACD (12,26,9)-0.49BullishMACD line is above its signal line
Bollinger band position46%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$11.79-0.5%
50-day SMA$13.79-14.9%
200-day SMA$12.51-6.2%

Recent price levels

LevelPrice
20-day high$12.73
20-day low$10.62
60-day high$16.29
60-day low$10.62
Upper Bollinger band$12.64
Lower Bollinger band$10.94

The 50-day average is currently 10.3% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility79.7%
Average true range4.56% of price
Max drawdown (1y)-32.4%
Volume (10d vs 90d)0.95x

Discussion

No comments yet — be the first to weigh in on ANGO.

Leave a comment

Scroll to Top